为产学研医“架桥”，生命健康前沿项目亮相概念验证大赛

Core Insights - The "Intelligent Action: Concept Verification Innovation Competition - Life and Health Special Roadshow" showcased cutting-edge health technology projects from top research institutions and universities in China, including the Chinese Academy of Sciences and Tsinghua University [1][2] Group 1: Project Highlights - The project on "Efficient Synthesis Technology Development of Single-Cell Protein Using Methanol-Utilizing Bacteria" aims to develop low-cost microbial protein as a substitute for soybean meal, addressing the significant risk posed by the reliance on imported soybean meal in China's feed industry [1] - The "AI-Driven mRNA Drug Manufacturing" project has developed a universal mRNA cancer vaccine that utilizes an AI-designed organ-targeting LNP delivery system, showing promising results in preclinical studies for tumor eradication and enhanced efficacy when combined with PD-1 inhibitors [1][2] Group 2: Event Overview - The roadshow featured various projects focusing on synthetic biology, AI drug development, brain-machine interfaces, precision medicine, and rehabilitation robotics, highlighting the intersection of health technology and clinical application [2] - Experts evaluated the projects based on technical feasibility, clinical application prospects, market competitiveness, and team strength, providing insights for future development from an industry and investment perspective [2] Group 3: Concept Verification Program - The "CAS Concept Verification Program," initiated in 2019, aims to facilitate the transition of early-stage technology projects from the laboratory to commercialization, significantly enhancing the efficiency of technology transfer [3] - The concept verification center plans to continue integrating research, clinical, industrial, and financial resources to support project teams in bringing innovative health technologies to market [3]